Reports for EMTRICITABINE

Ingredient

EMTRICITABINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-EMTRICITABINE/TENOFOVIR 200MG 300MG TABLET Resolved 2020-11-06 2021-01-07 128004
TEVA-EMTRICITABINE/TENOFOVIR 300MG 200MG TABLET Resolved 2022-04-21 2023-06-21 159201
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2018-04-27 2019-06-19 47356
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2019-06-25 2019-07-03 87463
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2021-04-12 2021-06-03 137370
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-09-15 2023-11-13 204524
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-01-02 2019-03-29 70748
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-04-03 2019-04-23 80423
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-04-23 2019-06-26 82201
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-07-03 2019-07-10 88291

Showing 1 to 10 of 28

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1